Express News | Drugs Made in America Acquisition Corp. Announces the Separate Trading of Its Ordinary Shares and Rights, Commencing February 25, 2025

ReutersFeb 20 16:30 ET

Drugs Made In America Acquisition Corp. Announces the Separate Trading of Its Ordinary Shares and Rights, Commencing February 25, 2025

GlobeNewswireFeb 20 16:30 ET

Express News | Trading Halt: Halt Status Updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

BenzingaJan 28 10:35 ET

Drugs Made in America Acquisition's 20M-Unit Initial Offering Prices at $10 a Unit

Dow JonesJan 27 17:31 ET

Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

GlobeNewswireJan 27 17:30 ET

Blank-Check Company Drugs Made In America Acquisition Corp. Files for $500M IPO

Dow JonesAug 1, 2024 16:08 ET